Mitsva Yekiriniki Yekuedza Mibairo yeKurapwa kweCOVID-19 Varwere Vekunze

0 nonse 3 | eTurboNews | eTN
rakanyorwa Linda Hohnholz

Kintor Pharmaceutical Limited, kambani yekiriniki-nhanho yebiotechnology inogadzira mamorekuru madiki uye biological therapeutics, yakazivisa kunyoreswa uye dosing yemurwere wayo wekutanga muChina mune yayo yakawanda-regional chikamu III chirongwa chekiriniki (NCT04869228) yeproxalutamide kurapwa kweCOVID-19. varwere vekunze muChipatara Chechitatu cheVanhu cheShenzhen kuChina muna Kukadzi 10, 2022.

Muyedzo wechikamu chechitatu ndeye randomized, kaviri-mapofu, placebo-inodzorwa, akawanda-regional kudzidza, yakagadzirirwa kuongorora kushanda uye kuchengetedzeka kweproxalutamide muvarume COVID-19 varwere. Muyedzo wechikamu chechitatu wakanyoresa varwere vangangosvika mazana maviri munzvimbo dziri munyika dzinosanganisira Brazil, Philippines neMalaysia. China ndiyo imwe yenyika dzakakosha dziri kutora chikamu mukutongwa kwematunhu akawanda, kwakatenderwa neChina NMPA musi waGunyana 200, 1. Nzvimbo dzinopinda muyedzo iyi muChina dzinosanganisira Beijing Ditan Hospital, China-Japan Friendship Hospital, yechitatu. Chipatara chePeople cheShenzhen, Shanghai Public Health Clinical Center, Hangzhou Xixi Hospital, Public Health Clinical Center yeChengdu uye Fifth People's Hospital yeSuzhou.

Dr. Tong Youzhi, muvambi, Sachigaro, uye CEO weKintor Pharma, vakatsinhira, “Tinoda kupa kutenda kwakakosha kuMutungamiri Dr. Hongzhou Lu nechikwata chavo vari muThird People's Hospital kuShenzhen nekutanga kunyoresa varwere uye kuverengera muchipatara. proxalutamide's phase III kiriniki kuyedzwa kwekurapa COVID-19 varwere vari kunze muChina, inova nhanho yakakosha kune iyi yakawanda-regional kiriniki kuyedza. Tichaita zvese zvatinogona kukoka mamwe masayiti muChina kuti apinde muongororo yakakosha iyi. Kunze kwezvo, kuyedzwa kwekiriniki kwevarwere veCCIDID-19 (NCT05009732) kwatanga kunyoreswa kwevarwere muUnited States, Ukraine nePhilippines, uye parizvino vari kuongorora varwere vasati vanyoreswa munzvimbo dzeChina. Tiri kuenderera mberi nechirongwa ichi mune dzimwe nyika dziri kutora chikamu muzviyedzo zvedu zvekiriniki zvematunhu akawanda. "

ZVOKUBVA MUNYAYA INO:

  • Kintor Pharmaceutical Limited, kambani yekiriniki-nhanho yebiotechnology inogadzira mamorekuru madiki uye biological therapeutics, yakazivisa kunyoreswa uye dosing yemurwere wayo wekutanga muChina mune yayo yakawanda-regional chikamu III chirongwa chekiriniki (NCT04869228) yeproxalutamide kurapwa kweCOVID-19. varwere vekunze muChipatara Chechitatu cheVanhu cheShenzhen kuChina muna Kukadzi 10, 2022.
  • Hongzhou Lu nechikwata chake muChipatara Chechitatu cheVanhu cheShenzhen chekutanga kunyoresa murwere uye dosing muproxalutamide's phase III kiriniki yekuyedza kurapa varwere veCCIDID-19 vari kunze muChina, inova nhanho yakakosha kune iyi yakawanda-regional kiriniki kuyedza.
  • Kunze kwezvo, kuyedzwa kwekiriniki kwevarwere veCCIDID-19 (NCT05009732) kwatanga kunyoreswa kwevarwere muUnited States, Ukraine nePhilippines, uye parizvino vari kuongorora varwere vasati vanyoreswa munzvimbo dzeChina.

<

Nezvomunyori

Linda Hohnholz

Editor mukuru we eTurboNews yakavakirwa muTN HQ.

Subscribe
Notify of
muenzi
0 Comments
Inline feedbacks
Ona zvese zvataurwa
0
Ndingade pfungwa dzako, ndapota taura.x
Govera ku...